ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 142 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $161,000 | -52.6% | 3,013 | 0.0% | 0.06% | -57.4% |
| Q4 2015 | $340,000 | -51.8% | 3,013 | -49.8% | 0.14% | -54.4% |
| Q3 2015 | $706,000 | +51.8% | 6,000 | 0.0% | 0.30% | +78.4% |
| Q2 2015 | $465,000 | +34.0% | 6,000 | 0.0% | 0.17% | +24.6% |
| Q1 2015 | $347,000 | +78.9% | 6,000 | 0.0% | 0.13% | +57.6% |
| Q4 2014 | $194,000 | +9.0% | 6,000 | -14.0% | 0.08% | -2.3% |
| Q3 2014 | $178,000 | +67.9% | 6,978 | +16.3% | 0.09% | +70.6% |
| Q2 2014 | $106,000 | +65.6% | 6,000 | 0.0% | 0.05% | +24.4% |
| Q3 2013 | $64,000 | +88.2% | 6,000 | 0.0% | 0.04% | +64.0% |
| Q2 2013 | $34,000 | – | 6,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |